The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Clinicians’ Use of ‘Safer’ Opioid-Prescribing Practices Spotty

Clinicians’ Use of ‘Safer’ Opioid-Prescribing Practices Spotty

March 5, 2019 • By Anne Harding

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“These are things that are not going to cause harm to your patients, so there’s really very little risk in doing them, but they do take up time,” he says. “Do we need to wait for a randomized controlled trial to say that we should be doing these things? Probably not.”

You Might Also Like
  • 10 Tips for Opioid Prescribing
  • How to Improve Opioid Prescribing in an Outpatient Clinic
  • U.S. Senator Launches Probe into 5 Top Opioid Drugmakers

Douglas Gourlay, MD, an addiction medicine physician and educational consultant in private practice in Hamilton, Canada, says, “We still haven’t come to grips with the notion that everything has risk, and the challenge is what do you do with that risk and how do you manage it.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

One unintended consequence of addressing the opioid epidemic by restricting supply is that patients who have been on long-term prescription opioids can no longer obtain them, which can lead to the patient getting the drugs illegally or even using street drugs, notes Dr. Gourlay, who was not involved in the study.

Clinicians can’t always judge who’s at risk of misusing opioids, he added, given the role of genetics, personal history and other factors in determining vulnerability to substance abuse. He and his colleagues were the first to propose the idea of using “universal precautions” in pain medicine in a 2005 article.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Physicians have always thought that they know their patients better than anyone else would know, but time and time again we really don’t know as much about our patients as we thought,” he says.


Reference

  1. Alford DP, Lazure P, Murray S, et al. National trends in prescription opioid risk mitigation practices: Implications for prescriber education. Pain Med. 2019 Feb 21. pii: pny298. [Epub ahead of print]

Pages: 1 2 | Single Page

Filed Under: Analgesics, Drug Updates Tagged With: opioid, Opioid abuse, opioid crisis, prescribing

You Might Also Like:
  • 10 Tips for Opioid Prescribing
  • How to Improve Opioid Prescribing in an Outpatient Clinic
  • U.S. Senator Launches Probe into 5 Top Opioid Drugmakers
  • FDA Says It Requires Boxed Warning on Some Opioid-Based Painkillers

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.